Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder

NCT01868516 is registered in ClinicalTrials.gov with Targacept Inc. as lead sponsor.

NCT NCT01868516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01868516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder
Lead sponsor
Targacept Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2013
Completion date
June 30, 2014
Enrollment
1,635 (actual)
Sites
125

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder